Community oncologists’ perceptions and utilization of large-panel genomic tumor testing

Abstract Purpose Large-panel genomic tumor testing (GTT) is an emerging technology with great promise but uncertain clinical value. Previous research has documented variability in academic oncologists’ perceptions and use of GTT, but little is known about community oncologists’ perceptions of GTT an...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Eric C. Anderson, Alexandra C. Hinton, Christine W. Lary, Anny T. H. R. Fenton, Andrey Antov, Emily Edelman, Petra Helbig, Kate Reed, Susan Miesfeldt, Christian A. Thomas, Michael J. Hall, J. Scott Roberts, Jens Rueter, Paul K. J. Han, MCGI Working Group
Format:	article
Langue:	EN
Publié:	BMC 2021
Sujets:	Genomic Cancer Uncertainty Attitudes Confidence Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/dbabf7f6cf97472f85681b1a23bd2da2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Community oncologists’ perceptions and utilization of large-panel genomic tumor testing

Documents similaires